Louisiana State Employees Retirement System’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.67M Buy
131,900
+1,200
+0.9% +$35.5K 0.07% 216
2026
Q1
$3.62M Buy
130,700
+9,500
+8% +$244K 0.06% 260
2025
Q4
$2.63M Buy
121,200
+1,400
+1% +$27.6K 0.05% 392
2025
Q3
$1.81M Buy
119,800
+1,400
+1% +$17.3K 0.03% 600
2025
Q2
$1.33M Buy
118,400
+500
+0.4% +$5.42K 0.02% 780
2025
Q1
$1.19M Sell
117,900
-1,300
-1% -$14.1K 0.02% 839
2024
Q4
$1.41M Sell
119,200
-1,700
-1% -$20.1K 0.03% 760
2024
Q3
$1.4M Buy
120,900
+25,200
+26% +$287K 0.03% 784
2024
Q2
$1.01M Sell
95,700
-1,300
-1% -$14.2K 0.02% 946
2024
Q1
$1.02M Buy
+97,000
New +$1.05M 0.02% 956

Other funds holding ROIV

Louisiana State Employees Retirement System's ROIV Position: Q2 2026 in Review

Louisiana State Employees Retirement System increased its Roivant Sciences (ROIV) stake by 0.92% in Q2 2026, buying an estimated $35.5K and bringing the position to 131,900 shares worth $4.67M. The position accounts for 0.07% of the portfolio, ranked #216.

Louisiana State Employees Retirement System first reported a position in ROIV in Q1 2024 and has held it in 10 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Louisiana State Employees Retirement System held 131,900 shares of Roivant Sciences worth $4.67M as of Q2 2026.
  • Louisiana State Employees Retirement System bought 1,200 Roivant Sciences shares in Q2 2026, an estimated $35.5K.
  • Roivant Sciences made up 0.07% of Louisiana State Employees Retirement System's portfolio in Q2 2026, its #216 holding.
  • Louisiana State Employees Retirement System first reported a position in Roivant Sciences in Q1 2024 and has held it in 10 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Louisiana State Employees Retirement System's 13F filing for Q2 2026, filed 20 Jul 2026.